Premium
Clinical Nanomaterials: A Safe‐by‐Design Strategy towards Safer Nanomaterials in Nanomedicines (Adv. Mater. 45/2019)
Author(s) -
Yan Liang,
Zhao Feng,
Wang Jing,
Zu Yan,
Gu Zhanjun,
Zhao Yuliang
Publication year - 2019
Publication title -
advanced materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.707
H-Index - 527
eISSN - 1521-4095
pISSN - 0935-9648
DOI - 10.1002/adma.201970325
Subject(s) - nanomaterials , nanotechnology , materials science , safer , nanomedicine , nanoparticle , computer science , computer security
In article number 1805391, Zhanjun Gu, Yuliang Zhao, and co‐workers review clinical potential and toxicological mechanisms of the most important nanomaterials, including liposomes, polymeric and biomacromolecular nanomaterials, inorganic nanomaterials, and carbon‐based nanomaterials with a view to avoiding potential adverse effects of emerging nanomedicines. Based on the available information, an overview of the principles in developing “safe‐by‐design” nanomaterials for medical applications is given.